Skip to main navigation Skip to search Skip to main content

Novel Antihypertensive Peptides Derived from Chicken Foot Proteins

  • F.I. Bravo
  • , A. Mas-Capdevila
  • , M. Margalef
  • , A. Arola-Arnal
  • , B. Muguerza

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.Scope: Chicken foot proteins have recently been demonstrated by the group to be a great source of hydrolysates with antihypertensive properties. The aim of this study was to isolate and identify angiotensin I-converting enzyme inhibitory (ACEI) peptides from chicken foot hydrolysate Hpp11 and to test their antihypertensive properties. Methods and Results: Peptides are separated into fractions according to their molecular size and hydrophobicity by ultrafiltration and RP-HPLC, respectively. Subsequent peptide identification in the two fractions that present the highest ACEI activities is carried out by HPLC-MS. Ten of the identified peptides are synthesized and five of them show ACEI (IC50) values lower than 100 µm. The antihypertensive effects of these ACEI peptides after oral administration is evaluated in spontaneously hypertensive rats. The peptides AVFQHNCQE and QVGPLIGRYCG exhibit antihypertensive activity when administered at an oral dose of 10 mg kg−1 body weight. The maximal decrease in systolic blood pressure is recorded 6 h after their administration (−25.07 ± 4.21 and −10.94 ± 1.96 mmHg, respectively). Conclusion: These results suggest that AVFQHNCQE and QVGPLIGRYCG could be used as functional ingredients with antihypertensive effects, although it would be necessary to perform bioavailability and clinical studies to demonstrate their efficiency in humans.
Original languageEnglish
Article number1801176
JournalMolecular Nutrition and Food Research
Volume63
Issue number12
DOIs
Publication statusPublished - 1 Jun 2019
Externally publishedYes

Funding

Conceptualization, B.M. and F.I.B.; Formal analysis, B.M., F.I.B., and A.M.-C.; Funding acquisition, B.M., F.I.B., and A.A.; Investigation, F.I.B and A.M.-C.; Methodology, F.I.B., A.M.-C., and M.M.; Supervision, B.M., F.I.B., and A.A.; Writing-Original Draft, F.I.B., A.M.-C., and M.M.; Writing—Review & Editing, B.M., F.I.B., M.M., and A.A. This work has been supported by Grant Numbers RETOS COLABORACIÓN: RTC-2017-6044-2 and AGL2016-77105-R from the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (FEDER). A. M.-C. is a recipient of a predoctoral fellowship from Universitat Rovira i Virgili- Martí i Franquès (Grant number: 2015PMF-PIPF-51). The authors want to thank Dr. Nuria Canela, Dr. Pol Herrero, Niurka Llópiz, and Rosa Pastor for their technical support. Conceptualization, B.M. and F.I.B.; Formal analysis, B.M., F.I.B., and A.M.-C.; Funding acquisition, B.M., F.I.B., and A.A.; Investigation, F.I.B and A.M.-C.; Methodology, F.I.B., A.M.-C., and M.M.; Supervision, B.M., F.I.B., and A.A.; Writing-Original Draft, F.I.B., A.M.-C., and M.M.; Writing— Review & Editing, B.M., F.I.B., M.M., and A.A. This work has been supported by Grant Numbers RETOS COLABORACIÓN: RTC-2017-6044-2 and AGL2016-77105-R from the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (FEDER). A. M.-C. is a recipient of a predoctoral fellowship from Universitat Rovira i Virgili-Martíi Franquès (Grant number: 2015PMF-PIPF-51). The authors want to thank Dr. Nuria Canela, Dr. Pol Herrero, Niurka Llópiz, and Rosa Pastor for their technical support.

FundersFunder number
Universitat Rovira i Virgili-Martíi Franquès2015PMF-PIPF-51
Federación Española de Enfermedades Raras
Ministerio de Economía y Competitividad
Universitat Rovira i Virgili
European Regional Development Fund

    Fingerprint

    Dive into the research topics of 'Novel Antihypertensive Peptides Derived from Chicken Foot Proteins'. Together they form a unique fingerprint.

    Cite this